Skip to main content

View full-text article in PMC

. 2019 Feb 6;11:13. doi: 10.1186/s13098-019-0410-5

Table 3.

Oxidative stress and adipokines in diabetic patients with hyperglycemic crises before and after treatment and the healthy controls (x ± s)

	Control	DKA		NKH
	Control	Before treatment	After treatment	Before treatment	After treatment
SOD (kU/L)	89.56 ± 14.16	48.76 ± 18.33^a	69.52 ± 16.31^ab	53.52 ± 14.70^a	70.35 ± 13.80^ab
MDA (µmol/L)	5.23 ± 2.57	11.37 ± 3.66^a	7.64 ± 2.90^ab	8.57 ± 3.01^a	6.07 ± 2.67^ab
TAC (kU/L)	29.51 ± 11.49	20.39 ± 10.61^a	24.27 ± 10.05^ab	20.95 ± 12.41^a	23.02 ± 11.23^ab
8-Iso-PGF2α (µg/L)	6.70 ± 2.33	18.42 ± 5.78^a	15.14 ± 6.21^ab	20.90 ± 4.70^a	13.44 ± 6.71^ab
Adiponectin (µg/L)	9.89 ± 1.63	5.77 ± 1.55^a	7.12 ± 1.63^ab	5.23 ± 1.11^a	8.06 ± 1.56^ab
Leptin (µg/L)	8.91 ± 1.73	6.07 ± 2.45^a	8.45 ± 2.13^b	5.91 ± 1.07^a	8.78 ± 2.65
Restistin (µg/L)	3.21 ± 1.07	8.35 ± 1.83^a	6.24 ± 1.50^ab	9.23 ± 2.06^a	7.14 ± 1.99^ab

DKA: diabetic ketoacidosis group; NKH: non-ketotic hyperglycemia group; control group: healthy individuals

^aP < 0.05, compared with controls

^bP < 0.05, compared with the same group before treatment